These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 16553532)

  • 21. Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study.
    Davidson J; Pearlstein T; Londborg P; Brady KT; Rothbaum B; Bell J; Maddock R; Hegel MT; Farfel G
    Am J Psychiatry; 2001 Dec; 158(12):1974-81. PubMed ID: 11729012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder.
    DelBello MP; Chang K; Welge JA; Adler CM; Rana M; Howe M; Bryan H; Vogel D; Sampang S; Delgado SV; Sorter M; Strakowski SM
    Bipolar Disord; 2009 Aug; 11(5):483-93. PubMed ID: 19624387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment strategies in patients with major depression not responding to first-line sertraline treatment. A randomised study of extended duration of treatment, dose increase or mianserin augmentation.
    Licht RW; Qvitzau S
    Psychopharmacology (Berl); 2002 May; 161(2):143-51. PubMed ID: 11981594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sertraline in children and adolescents with major depressive disorder.
    Donnelly CL; Wagner KD; Rynn M; Ambrosini P; Landau P; Yang R; Wohlberg CJ
    J Am Acad Child Adolesc Psychiatry; 2006 Oct; 45(10):1162-1170. PubMed ID: 17003661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
    Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
    Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An open-label pilot study of St. John's wort in juvenile depression.
    Findling RL; McNamara NK; O'Riordan MA; Reed MD; Demeter CA; Branicky LA; Blumer JL
    J Am Acad Child Adolesc Psychiatry; 2003 Aug; 42(8):908-14. PubMed ID: 12874492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluoxetine 40-60 mg versus fluoxetine 20 mg in the treatment of children and adolescents with a less-than-complete response to nine-week treatment with fluoxetine 10-20 mg: a pilot study.
    Heiligenstein JH; Hoog SL; Wagner KD; Findling RL; Galil N; Kaplan S; Busner J; Nilsson ME; Brown EB; Jacobson JG
    J Child Adolesc Psychopharmacol; 2006; 16(1-2):207-17. PubMed ID: 16553541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
    Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
    J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multicenter open-label sertraline study in adolescent outpatients with major depression.
    Ambrosini PJ; Wagner KD; Biederman J; Glick I; Tan C; Elia J; Hebeler JR; Rabinovich H; Lock J; Geller D
    J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):566-72. PubMed ID: 10230188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial.
    Kasper S; Volz HP; Möller HJ; Dienel A; Kieser M
    Eur Neuropsychopharmacol; 2008 Nov; 18(11):803-13. PubMed ID: 18694635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of levomilnacipran sustained release in moderate to severe major depressive disorder: a randomized, double-blind, placebo-controlled, proof-of-concept study.
    Montgomery SA; Mansuy L; Ruth A; Bose A; Li H; Li D
    J Clin Psychiatry; 2013 Apr; 74(4):363-9. PubMed ID: 23656841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting placebo response in adolescents with major depressive disorder: The Adolescent Placebo Impact Composite Score (APICS).
    Nakonezny PA; Mayes TL; Byerly MJ; Emslie GJ
    J Psychiatr Res; 2015 Sep; 68():346-53. PubMed ID: 26028546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment benefit and the risk of suicidality in multicenter, randomized, controlled trials of sertraline in children and adolescents.
    March JS; Klee BJ; Kremer CM
    J Child Adolesc Psychopharmacol; 2006; 16(1-2):91-102. PubMed ID: 16553531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of pentoxifylline combination therapy in major depressive disorder: a randomized, double-blind, placebo-controlled clinical trial.
    Farajollahi-Moghadam M; Sanjari-Moghaddam H; Ghazizadeh Hasemi M; Sanatian Z; Talaei A; Akhondzadeh S
    Int Clin Psychopharmacol; 2021 May; 36(3):140-146. PubMed ID: 33724254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A placebo-controlled, randomized withdrawal study of sertraline for major depressive disorder in Japan.
    Kamijima K; Burt T; Cohen G; Arano I; Hamasaki T
    Int Clin Psychopharmacol; 2006 Jan; 21(1):1-9. PubMed ID: 16317311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The combination of triiodothyronine (T3) and sertraline is not superior to sertraline monotherapy in the treatment of major depressive disorder.
    Garlow SJ; Dunlop BW; Ninan PT; Nemeroff CB
    J Psychiatr Res; 2012 Nov; 46(11):1406-13. PubMed ID: 22964160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An open trial of citalopram in children and adolescents with depression.
    Shirazi E; Alaghband-Rad J
    J Child Adolesc Psychopharmacol; 2005 Apr; 15(2):233-9. PubMed ID: 15910207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized trial of a specific adherence enhancement program in sertraline-treated adults with major depressive disorder in a primary care setting.
    Kutcher S; Leblanc J; Maclaren C; Hadrava V
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Apr; 26(3):591-6. PubMed ID: 11999913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic Review: The Measurement Properties of the Children's Depression Rating Scale-Revised in Adolescents With Major Depressive Disorder.
    Stallwood E; Monsour A; Rodrigues C; Monga S; Terwee C; Offringa M; Butcher NJ
    J Am Acad Child Adolesc Psychiatry; 2021 Jan; 60(1):119-133. PubMed ID: 33130251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.